Protect-me: a parallel-group, triple blinded, placebo-controlled randomised clinical trial protocol assessing antenatal maternal melatonin supplementation for fetal neuroprotection in early-onset fetal growth restriction
IntroductionFetal growth restriction (FGR) is a serious pregnancy complication, associated with increased rates of perinatal death and morbidity among survivors. Most commonly FGR results from placental insufficiency, where the placenta fails to deliver the oxygen and nutrients required for normal f...
Main Authors: | Miranda L Davies-Tuck, Kirsten R Palmer, Joanne C Mockler, Suzanne L Miller, Michael C Fahey, Katie M Groom, Euan M Wallace |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2019-06-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/9/6/e028243.full |
Similar Items
-
Melatonin as fetal neuroprotection: Links and risks
by: Fahimeh Ghotbizadeh Vahdani, et al.
Published: (2020-12-01) -
The Beneficial Effects of Melatonin Administration Following Hypoxia-Ischemia in Preterm Fetal Sheep
by: Tamara Yawno, et al.
Published: (2017-09-01) -
Author reply to letter to editor “melatonin as fetal neuroprotection: Links and risks”
by: Reyin Lien
Published: (2020-12-01) -
Antenatal magnesium sulphate administration for fetal neuroprotection: a French national survey
by: Clément Chollat, et al.
Published: (2017-09-01) -
Antenatal fetal monitoring /
by: 454201 Bennett, M. J.